Literature DB >> 21715533

Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma.

Arne Heilo1, Eva Sigstad, Kristin Holgersen Fagerlid, Olav Inge Håskjold, Krystyna Kotanska Grøholt, Aasmund Berner, Trine Bjøro, Lars H Jørgensen.   

Abstract

CONTEXT: Repeated neck explorations can be a difficult task in patients with recurrent metastatic cervical lymph nodes from papillary thyroid carcinoma (PTC).
OBJECTIVE: The aim of this retrospective study has been to assess the efficacy of ultrasound (US)-guided percutaneous ethanol injection (PEI) as treatment of metastatic cervical lymph nodes from PTC.
MATERIALS AND METHODS: Sixty-nine patients who previously had undergone thyroidectomy for PTC were selected for inclusion. However, three patients were later excluded due to lack of follow-up. Lymph node status was determined by US-guided fine-needle aspiration biopsy and/or by raised levels of thyroglobulin in washouts from the cytological needle. Guided by US, 0.1-1.0 ml of 99.5% ethanol was injected into the metastatic lymph nodes.
RESULTS: Three patients (eight metastatic lymph nodes in total) were reassigned to surgery due to progression (multiple new metastases), leaving 63 patients and 109 neck lymph nodes to be included. Mean observation time was 38.4 months (range, 3-72). A total of 101 of the 109 (93%) metastatic lymph nodes responded to PEI treatment, 92 (84%) completely and nine incompletely. Two did not respond, and four progressed. Two lymph nodes previously considered successfully treated showed evidence of malignancy during follow-up. No significant side effects were reported.
CONCLUSION: US-guided PEI treatment of metastatic lymph nodes seems to be an excellent alternative to surgery in patients with a limited number of neck metastases from PTC. This procedure should replace "berry picking" surgery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21715533     DOI: 10.1210/jc.2010-2952

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

1.  Surgeon-performed intraoperative tumor localization in recurrent papillary thyroid carcinoma by ultrasound-guided intratumoral indigo carmine injection.

Authors:  Dongbin Ahn; Jin Ho Sohn; Heejin Kim
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

2.  Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer.

Authors:  Sae Rom Chung; Jung Hwan Baek; Young Jun Choi; Jeong Hyun Lee
Journal:  Eur Radiol       Date:  2019-02-25       Impact factor: 5.315

3.  Percutaneous Microwave Ablation of Metastatic Lymph Nodes from Papillary Thyroid Carcinoma: Preliminary Results.

Authors:  Wei Zhou; Yudong Chen; Lu Zhang; Xiaofeng Ni; Shangyan Xu; Weiwei Zhan
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

4.  Safety and efficiency of ultrasound-guided low power microwave ablation in the treatment of cervical metastatic lymph node from papillary thyroid carcinoma: a mean of 32 months follow-up study.

Authors:  Dengke Teng; Lei Ding; Yu Wang; Caimei Liu; Yongxu Xia; Hui Wang
Journal:  Endocrine       Date:  2018-08-13       Impact factor: 3.633

5.  Thyroglobulin Liquid Chromatography-Tandem Mass Spectrometry Has a Low Sensitivity for Detecting Structural Disease in Patients with Antithyroglobulin Antibodies.

Authors:  Umal Azmat; Kyle Porter; Leigha Senter; Matthew D Ringel; Fadi Nabhan
Journal:  Thyroid       Date:  2016-11-09       Impact factor: 6.568

6.  Long-term outcomes of ethanol injection therapy for locally recurrent papillary thyroid cancer.

Authors:  Soo Young Kim; Seok-Mo Kim; Hojin Chang; Bup-Woo Kim; Chi Young Lim; Yong Sang Lee; Hang-Seok Chang; Cheong Soo Park
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-29       Impact factor: 2.503

7.  2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer.

Authors:  L Leenhardt; M F Erdogan; L Hegedus; S J Mandel; R Paschke; T Rago; G Russ
Journal:  Eur Thyroid J       Date:  2013-09-05

Review 8.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

9.  European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the Use of Minimally Invasive Treatments in Malignant Thyroid Lesions.

Authors:  Giovanni Mauri; Laszlo Hegedüs; Steven Bandula; Roberto Luigi Cazzato; Agnieszka Czarniecka; Oliver Dudeck; Laura Fugazzola; Romana Netea-Maier; Gilles Russ; Göran Wallin; Enrico Papini
Journal:  Eur Thyroid J       Date:  2021-05-25

Review 10.  Thyroid nodules and cancer management guidelines: comparisons and controversies.

Authors:  Fadi Nabhan; Matthew D Ringel
Journal:  Endocr Relat Cancer       Date:  2016-12-13       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.